Delivery Order SPE2DB22D1106-SPE2DB24FEKA9
Award Date
4/5/24
Potential Completion Date
4/8/24
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,545,937 units of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The contract has a total potential value of $5,276.45 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to deliver this...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,248,064 units of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $4,789.49 and a period of performance through April 12, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to...
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceuticals. The $10,299.41 contract has a performance period through February 6, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which is placed against a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the provision of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The $1,319.92 firm-fixed-price contract has an ultimate completion date of May 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceuticals. The contract, valued at $2,916.87, has a completion date of February 28, 2024. AmerisourceBergen Drug Corp, a subsidiary of the for-profit organization Cencora, Inc. doing business as AmerisourceBergen, serves as the prime contractor. This award is not associated with any...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. The $2,140.52 order has a completion date of February 27, 2024 and was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as Amerisourcebergen's primary contract vehicle to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has a ceiling value of $62,156.88 and a period of performance through March 4, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The $3,421.00 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 indefinite delivery contract with DLA as the primary vehicle for delivering pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $2,052.90 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 25 mcg/0.5 mL TYPHIM VI syringes by May 1, 2024. This award is under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,089,219 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The $15,638.09 contract has a performance period through March 27, 2024 and does not include any set-aside designations. AmerisourceBergen Drug Corp also holds an indefinite delivery contract with the...